A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
High Grade Serous Ovarian Cancer
Head and Neck Squamous Cell Carcinoma
Colorectal Cancer
Castration-resistant Prostate Cancer
Non Small Cell Lung Cancer
Endometrium Cancer
Triple Negative Breast Cancer

Interventions

DRUG: IDE034

Sponsor

IDEAYA Biosciences